Centessa Pharmaceuticals plc - ADR
CNTA
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.15B
Close$
$0.48
98.8% downside
Current Fair Value
98.8% downsideOvervalued by 98.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.15 Billion |
|---|---|
| Enterprise Value | $6.10 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.46 |
| Beta | 1.14 |
| Outstanding Shares | 153,549,733 |
Return
| Return on Equity | -51.43% |
|---|---|
| Return on Assets | -39.05% |
| Return on Invested Capital | -44.25% |
Valuation & Multiples
| P/E Ratio | -24.36 |
|---|---|
| PEG | -11.99 |
| Price to Sales | - |
| Price to Book Ratio | 13.28 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -22.77 |
| Enterprise Value to Net Income | -25 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 18, 2026
EPS Estimate
$-0.37
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.40
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.6263▲ 11.93% |
|---|---|
| Total Calls | 726,700▲ 52.54% |
| Total Puts | 455,100▲ 88.45% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 109.52%▲ 2.37% |
|---|---|
| Total Invested | $5.90B▲ 64.01% |
| Investors Holding | 174▲ 17.00% |
ESG Score
No data
About Centessa Pharmaceuticals plc
2,021 employees